Library
Log In
Log in with your UoM account
Problems logging in with your UoM account?
or
Guest login
Email address
Password
No UoM account? Click here to register a guest account.
Have you forgotten your guest credentials?
Library
FAQs
Communities & Collections
Browse Repository
Statistics
My Lists
search
Search
Log In
Log in with your UoM account
Problems logging in with your UoM account?
or
Guest login
Email address
Password
No UoM account? Click here to register a guest account.
Have you forgotten your guest credentials?
Home
Minerva Access
Collected Works
Minerva Elements
Minerva Elements Records
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.